Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Review of Ongoing Activities and Challenges to Improve the Care of Patients With Type 2 Diabetes Across Africa and the Implications for the Future.

Godman B, Basu D, Pillay Y, Mwita JC, Rwegerera GM, Anand Paramadhas BD, Tiroyakgosi C, Okwen PM, Niba LL, Nonvignon J, Sefah I, Oluka M, Guantai AN, Kibuule D, Kalemeera F, Mubita M, Fadare J, Ogunleye OO, Distiller LA, Rampamba EM, Wing J, Mueller D, Alfadl A, Amu AA, Matsebula Z, Kalungia A, Zaranyika T, Masuka N, Wale J, Hill R, Kurdi A, Timoney A, Campbell S, Meyer JC.

Front Pharmacol. 2020 Mar 20;11:108. doi: 10.3389/fphar.2020.00108. eCollection 2020. Review.

PMID:
32265688
2.

Fixed dose drug combinations - are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries.

Godman B, McCabe H, D Leong T, Mueller D, Martin AP, Hoxha I, Mwita JC, Rwegerera GM, Massele A, Costa JO, do Nascimento RCRM, Lemos LLP, Tachkov K, Milushewa P, Patrick O, Niba LL, Laius O, Sefah I, Abdulsalim S, Soleymani F, Guantai AN, Achieng L, Oluka M, Jakupi A, Logviss K, Hassali MA, Kibuule D, Kalemeera F, Mubita M, Fadare J, Ogunleye OO, Saleem Z, Hussain S, Bochenek T, Mardare I, Alrasheedy AA, Furst J, Tomek D, Markovic-Pekovic V, Rampamba EM, Alfadl A, Amu AA, Matsebula Z, Phuong TNT, Thanh BN, Chichonyi Kalungia A, Zaranyika T, Masuka N, Olaru ID, Wale J, Hill R, Kurdi A, Timoney A, Campbell S, Meyer JC.

Expert Rev Pharmacoecon Outcomes Res. 2020 Apr 1:1-26. doi: 10.1080/14737167.2020.1734456. [Epub ahead of print]

PMID:
32237953
3.

Predictors of loss to follow-up of tuberculosis cases under the DOTS programme in Namibia.

Kibuule D, Aiases P, Ruswa N, Rennie TW, Verbeeck RK, Godman B, Mubita M.

ERJ Open Res. 2020 Mar 16;6(1). pii: 00030-2019. doi: 10.1183/23120541.00030-2019. eCollection 2020 Jan.

4.

Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future.

Godman B, Basu D, Pillay Y, Almeida PHRF, Mwita JC, Rwegerera GM, Anand Paramadhas BD, Tiroyakgosi C, Patrick O, Niba LL, Sefah I, Oluka M, Guantai AN, Kibuule D, Kalemeera F, Mubita M, Fadare J, Ogunleye OO, Rampamba EM, Wing J, Mueller D, Alfadl A, Amu AA, Matsebula Z, Kalungia A, Zaranyika T, Masuka N, Wale J, Hill R, Kurdi A, Timoney A, Campbell S, Meyer JC.

Hosp Pract (1995). 2020 Mar 20. doi: 10.1080/21548331.2020.1745509. [Epub ahead of print]

PMID:
32196395
5.

A robust tool for recording pharmacist's interventions in a low-resource setting.

Rennie T, Anguuo L, Corkhill N, Mubita M, Hunter CJ.

Eur J Intern Med. 2019 Jul;65:e11-e12. doi: 10.1016/j.ejim.2019.05.001. Epub 2019 May 10. No abstract available.

PMID:
31079935
6.

Monitoring of gentamicin serum concentrations in obstetrics and gynaecology patients in Namibia.

Singu BS, Mubita M, Thikukutu MM, Mufenda JK, McKenzie SB, Verbeeck RK.

Int J Clin Pharm. 2018 Jun;40(3):520-525. doi: 10.1007/s11096-018-0626-8. Epub 2018 Mar 28.

PMID:
29594677
7.

Assessing Adherence to Antihypertensive Therapy in Primary Health Care in Namibia: Findings and Implications.

Nashilongo MM, Singu B, Kalemeera F, Mubita M, Naikaku E, Baker A, Ferrario A, Godman B, Achieng L, Kibuule D.

Cardiovasc Drugs Ther. 2017 Dec;31(5-6):565-578. doi: 10.1007/s10557-017-6756-8.

8.

Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia's national referral hospital: a pilot study and the implications.

Nakwatumbah S, Kibuule D, Godman B, Haakuria V, Kalemeera F, Baker A, Mubita M.

Expert Rev Anti Infect Ther. 2017 Jul;15(7):713-721. doi: 10.1080/14787210.2017.1320220. Epub 2017 May 5.

9.

An analysis of policies for cotrimoxazole, amoxicillin and azithromycin use in Namibia's public sector: Findings and therapeutic implications.

Kibuule D, Mubita M, Naikaku E, Kalemeera F, Godman BB, Sagwa E.

Int J Clin Pract. 2017 Feb;71(2). doi: 10.1111/ijcp.12918. Epub 2017 Jan 16.

10.

Effect of changing from first- to second-line antiretroviral therapy on renal function: a retrospective study based on data from a single health facility in Namibia.

Kalemeera F, Mbango C, Mubita M, Naikaku E, Gaida R, Godman B.

Expert Rev Anti Infect Ther. 2016 Aug;14(8):777-83. doi: 10.1080/14787210.2016.1202759. Epub 2016 Jul 14. Erratum in: Expert Rev Anti Infect Ther. 2016 Sep;14(9):873.

PMID:
27309846
11.

Outcome of the first Medicines Utilization Research in Africa group meeting to promote sustainable and rational medicine use in Africa.

Massele A, Burger J, Katende-Kyenda NL, Kalemeera F, Kenaope T, Kibuule D, Mbachu O, Mubita M, Oluka M, Olusanya A, Paramadhas BD, van Zyl P, Godman B.

Expert Rev Pharmacoecon Outcomes Res. 2015;15(6):885-8. doi: 10.1586/14737167.2015.1088386. Epub 2015 Sep 14.

12.

Levamisole treatment in HIV-infected Zambian children.

Castro Garzón M, Mubita M, Kachinka L.

Lancet. 1992 Oct 31;340(8827):1099-100. No abstract available.

PMID:
1357488
13.

Case report: cholera in a preterm neonate.

Ngoma MP, Mubita M, Malowa H, Mbelenga M.

J Trop Med Hyg. 1992 Apr;95(2):152.

PMID:
1560488

Supplemental Content

Loading ...
Support Center